Brandt L, Kormann J
Anaesthesist. 1986 Mar;35(3):177-83.
Tricyclic antidepressants (TAD) are administered for therapy of nearly all types of depression. Interactions with anaesthetics are well known and are reported frequently in the literature. A case report about incidental findings from a series of experimental anaesthesias in healthy volunteers using different inhalation anaesthetics is presented enabling discussion of the problem of a possibly increased risk of anaesthesia in the presence of chronic TAD medication. 16 unpremedicated healthy subjects (mean age 27 +/- 4 y) received, at intervals of four weeks, inhalation anaesthesia by breathing spontaneously one of the volatile anaesthetics halothane, enflurane, or isoflurane in oxygen. The aim of the study was to investigate the influence of volatile anaesthetics on the human electroencephalogram. When evaluating the results an atypical increase of heart rate during anaesthesia was noticed in one subject. This tachycardia appeared during all three types of anaesthesia, all other observed parameters being normal. With the knowledge of these facts the volunteer was interviewed more thoroughly. He then admitted to have taken daily 125-175 mg of the TAD amitriptyline during the whole period of experiments (self-medication from lover's grief). We supposed therefore that the tachycardia during anaesthesia could be interpreted as an interaction between the TAD amitriptyline and the volatile anaesthetics halothane, enflurane, and isoflurane. After having discontinued TAD medication for some months, the volunteer, a medical student, repeated the experimental isoflurane anaesthesia with all other conditions identical. This time his heart rate did not differ from that of the other subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
三环类抗抑郁药(TAD)用于治疗几乎所有类型的抑郁症。其与麻醉剂的相互作用广为人知,且在文献中屡有报道。本文呈现了一份病例报告,内容来自一系列针对健康志愿者使用不同吸入麻醉剂的实验性麻醉中的偶然发现,有助于讨论在长期服用TAD药物的情况下麻醉风险可能增加的问题。16名未接受术前用药的健康受试者(平均年龄27±4岁)每隔四周接受一次吸入麻醉,通过自主呼吸在氧气中吸入挥发性麻醉剂氟烷、恩氟烷或异氟烷中的一种。该研究的目的是调查挥发性麻醉剂对人类脑电图的影响。在评估结果时,一名受试者在麻醉期间出现了非典型的心率增加。这种心动过速在所有三种麻醉类型中均出现,其他所有观察参数均正常。了解这些情况后,对该志愿者进行了更深入的访谈。他随后承认在整个实验期间每天服用125 - 175毫克的TAD阿米替林(因失恋自行用药)。因此,我们认为麻醉期间的心动过速可解释为TAD阿米替林与挥发性麻醉剂氟烷、恩氟烷和异氟烷之间的相互作用。在停用TAD药物几个月后,这位志愿者(一名医学生)在所有其他条件相同的情况下重复了异氟烷实验性麻醉。这次他的心率与其他受试者无异。(摘要截选至250字)